Results 21 to 30 of about 2,308 (202)

Postthrombotic Syndrome in Patients Treated With Rivaroxaban or Warfarin for Venous Thromboembolism [PDF]

open access: yesClinical and Applied Thrombosis/Hemostasis, 2018
Craig I Coleman   +2 more
exaly   +2 more sources

Endovascular Thrombus Removal for Treating Post-Partum Iliofemoral Deep Vein Thrombosis: A Single-Centre Retrospective Cohort Study

open access: yesClinical and Applied Thrombosis/Hemostasis, 2023
Objective To evaluate the safety and efficacy of percutaneous thrombectomy for treating postpartum iliofemoral vein thrombosis. Methods A retrospective analysis was performed on patients with continuous postpartum acute symptomatic iliofemoral deep vein ...
Xuexun Zheng MS   +3 more
doaj   +1 more source

Pharmacomechanical catheter-directed thrombolysis: An emerging therapy for deep vein thrombosis – A case series

open access: yesIndian Journal of Vascular and Endovascular Surgery, 2021
Venous thromboembolism comprising pulmonary embolism and deep-vein thrombosis (DVT) is a major health problem with DVT accounting for two-third of them.
Arumugam Aashish   +3 more
doaj   +1 more source

Long-term results of pathogenetically-grounded methods of treatment of patients with postthrombotic syndrome of the lower extremities according to three-year follow-up

open access: yesMedičnì Perspektivi, 2022
The aim of this study was to evaluate the effectiveness of surgical treatment using a modified method of correction of venous hemodynamic disorders of the lower extremities by the state of function of the leg muscle pump during long-term follow-up in ...
V.A. Orynchak , О.І. Gudz
doaj   +1 more source

New perspectives for prevention of the post-thrombotic syndrome

open access: yesBleeding, Thrombosis and Vascular Biology, 2022
While on conventional anticoagulation, up to 50% of patients with one or more episodes of proximal deep vein thrombosis (DVT) can develop post-thrombotic (PTS) manifestations.
Paolo Prandoni
doaj   +1 more source

Predicting venous thromboembolism (VTE) risk in cancer patients using machine learning

open access: yesHealth Care Science, Volume 2, Issue 4, Page 205-222, August 2023., 2023
In this study, we examined the utility of using machine learning (ML) to predict venous thromboembolism (VTE) in cancer patients. It allowed us to draw insight into our feature pool and identify the features that could have the most utility in the context of developing an efficient ML classifier. Our ML‐based prediction model achieved an area under the
Samir Khan Townsley   +5 more
wiley   +1 more source

Quality of life 1 month after acute pulmonary embolism in emergency department patients

open access: yesAcademic Emergency Medicine, Volume 30, Issue 8, Page 819-831, August 2023., 2023
Abstract Objective The Pulmonary Embolism Quality‐of‐Life (PEmb‐QoL) questionnaire assesses quality of life (QoL) after pulmonary embolism (PE). We aimed to determine whether any clinical or pathophysiologic features of PE were associated with worse PEmb‐QoL scores 1 month after PE.
Anthony J. Weekes   +15 more
wiley   +1 more source

Global Research Hotspots in Venous Thromboembolism Anticoagulation: A Knowledge‐Map Analysis from 2012 to 2021

open access: yesJournal of Interventional Cardiology, Volume 2023, Issue 1, 2023., 2023
Background. Venous thromboembolism (VTE) is a common cardiovascular disease that seriously threatens human lives. Anticoagulant therapy is considered to be the cornerstone of VTE treatment. An increasing number of studies has been updated in the VTE anticoagulation field.
Jia Wang   +8 more
wiley   +1 more source

Predictive factors of venous stenting failure: a systematic review

open access: yesAngiologia e Cirurgia Vascular, 2023
OBJECTIVE: Venous stenting of iliocaval obstructions has become a more frequent procedure over the last two decades. In-stent stenosis and thrombosis are potential complications, causing one of the main causes of symptoms recurrence and impacting ...
Ana Carolina Semião   +7 more
doaj   +1 more source

Causal relationship between 14 site‐specific cancers and venous thromboembolism

open access: yesCancer Innovation, Volume 1, Issue 4, Page 316-327, December 2022., 2022
Using Mendelian randomization study, we elucidated the causal effect between 14 site‐specific cancers and venous thromboembolism. Non‐Hodgkin's lymphoma increases risk of venous thromboembolism while melanoma decreases its risk. footnotes: VTE: venous thromboembolism; some icons were referenced from the Biorender (https://biorender.com/).
Xiong Chen   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy